GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
98 hedge funds and large institutions have $306M invested in GenMark Diagnostics, Inc in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
-1
Holders Change %
-1.01%
% of All Funds
2.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
33
Reduced
29
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CC
Casdin Capital
New York
|
+$6.09M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$2.25M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$1.8M |
| 4 |
PWP
Private Wealth Partners
Mill Valley,
California
|
+$1.63M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$979K |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$8.29M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.81M |
| 3 |
Millennium Management
New York
|
-$2.95M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$2.09M |
| 5 |
Two Sigma Investments
New York
|
-$1.76M |
